Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | MIF | P14174 | 1/20 | 0.35 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.35 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.35 |
| ▸ | HTR3B | O95264 | 1/20 | 0.35 |
| ▸ | PLAU | P00749 | 1/20 | 0.35 |
| ▸ | HTR3A | P46098 | 1/20 | 0.35 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.35 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | NOS3 | P29474 | 2/20 | 0.33 |
| ▸ | NOS1 | P29475 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14406571 | 0.94 | ALDH1A1 (0.36) | ALDH1A1CA2CA4CA5AMAPT | |
| SCHEMBL14406594 | 0.87 | ALDH1A1 (0.36) | ALDH1A1CA2CA4CA5AMAPT | |
| SCHEMBL14406587 | 0.87 | ALDH1A1 (0.36) | ALDH1A1CA2CA4CA5AMAPT | |
| SCHEMBL14406578 | 0.87 | ALDH1A1 (0.36) | ALDH1A1CA2CA4CA5AMAPT | |
| SCHEMBL14406559 | 0.86 | ALDH1A1 (0.35) | ALDH1A1CA2CA4CA5AMAPT | |
| SCHEMBL15328973 | 0.84 | MAPT (0.52) | ALDH1A1MAPTMEN1KMT2ANOS3 | |
| SCHEMBL14406560 | 0.82 | ALDH1A1 (0.40) | ALDH1A1MAPTMEN1KMT2ATDP1 | |
| SCHEMBL14406580 | 0.80 | CA2 (0.31) | ALDH1A1CA2CA4CA5A | |
| SCHEMBL14406593 | 0.79 | CRHBP (0.31) | — | |
| SCHEMBL14406573 | 0.78 | CA2 (0.36) | ALDH1A1CA2CA4CA5AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11502329-B2 | Pre-cell formation electrodes and lithium ion batteries | GOTION, INC. (US) | 2022-11-15 | — | — | US | claimed |
| US-20170025707-A1 | Lithium-ion Batteries and Preparation Method Thereof | SHENZHEN CAPCHEM TECHNOLOGY CO., LTD. (CN) | 2017-01-26 | — | — | US | claimed |
| US-12334502-B2 | Electrolytes for lithium-containing battery cells | APPLE INC. (US) | 2025-06-17 | — | — | US | disclosed |
| WO-2025038427-A1 | ELECTRODE COMPOSITIONS COMPRISING SILICON ALLOYS OF ALUMINUM NITRIDE AND BATTERIES CONTAINING THE SAME | Trion Energy Solutions Corp. (US) | 2025-02-20 | — | — | WO | disclosed |
| US-20240136585-A1 | ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS | APPLE INC. (US) | 2024-04-25 | — | — | US | disclosed |
| US-11916198-B2 | Fast-charging lithium ion batteries with electrolytes that do not react on the anodes | StoreDot Ltd. (IL) | 2024-02-27 | — | — | US | disclosed |
| US-11881558-B2 | Electrolytes for lithium-containing battery cells | APPLE INC. (US) | 2024-01-23 | — | — | US | disclosed |
| US-11824189-B2 | Layered high capacity electrodes | SOUTH DAKOTA BOARD OF REGENTS (US) | 2023-11-21 | — | — | US | disclosed |
| US-20230335785-A1 | HIGH-CONCENTRATION LITHIUM-ION ELECTROLYTES FOR BATTERY CELLS | APPLE INC. (US) | 2023-10-19 | — | — | US | disclosed |
| US-11787965-B2 | Ink composition for forming an organic layer of a semiconductor | NOVALED GMBH (DE) | 2023-10-17 | — | — | US | disclosed |
| US-11787965-B2 | Ink composition for forming an organic layer of a semiconductor | NOVALED GMBH (DE) | 2023-10-17 | — | — | US | disclosed |
| US-20090167158-A1 | Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2009-07-02 | — | — | US | disclosed |
| US-7235311-B2 | Electroluminescent devices incorporating mixed metal organic complexes | OLED-T LIMITED (GB) | 2007-06-26 | — | — | US | disclosed |
| US-7199129-B2 | Derivatives of morphine-like opioid compounds | MONASH UNIVERSITY (AU) | 2007-04-03 | — | — | US | disclosed |
| US-20070004684-A1 | Alpha-Carbolines as CDK-1 inhibitors | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| EP-1423392-B1 | DERIVATIVES OF MORPHINE-LIKE OPIOID COMPOUNDS | NEURO THERAPEUTICS LTD (AU) | 2006-10-04 | — | — | EP | disclosed |
| US-20040242616-A1 | Derivatives of morphine-like opioid compounds | NEURO THERAPEUTICS LIMITED (AU) | 2004-12-02 | — | — | US | disclosed |
| EP-0220516-B1 | PROCESS FOR THE PRODUCTION OF AROMATIC CARBOXYLIC-ACID CHLORIDES | BAYER AG (DE) | 1989-01-04 | — | — | EP | disclosed |
| US-4764310-A | Process for the preparation of aromatic carboxylic acid chlorides | BAYER AKTIENGESELLSCHAFT (DE) | 1988-08-16 | — | — | US | disclosed |
| EP-0220516-A1 | Process for the production of aromatic carboxylic-acid chlorides | BAYER AG (DE) | 1987-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240136585-A1 | ELECTROLYTES FOR LITHIUM-CONTAINING BATTERY CELLS | CEL, CA3, SLC9B2 | ALDH1A1 2487/4885CA2 13/4885CA4 112/4885 |
| US-20040242616-A1 | Derivatives of morphine-like opioid compounds | OPRM1, OPRK1, OPRD1 | ALDH1A1 450/4885CA2 1654/4885CA4 3069/4885 |
| US-20070004684-A1 | Alpha-Carbolines as CDK-1 inhibitors | CDKL1, CDK1, CCNA1 | ALDH1A1 1062/4885CA2 2025/4885CA4 2650/4885 |
| US-11881558-B2 | Electrolytes for lithium-containing battery cells | CEL, CA3, SLC9B2 | ALDH1A1 2487/4885CA2 13/4885CA4 112/4885 |
| US-12334502-B2 | Electrolytes for lithium-containing battery cells | CEL, CA3, SLC9B2 | ALDH1A1 2487/4885CA2 13/4885CA4 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.